Skip to main content
Clinical Trials/NCT00420407
NCT00420407
Terminated
Early Phase 1

Prospective, Randomized, Double-Blind, Multi-Center Trial of Low Dose Vasopressin Versus Placebo in Traumatic Shock Resuscitation

The University of Texas Health Science Center at San Antonio1 site in 1 country81 target enrollmentFebruary 2007

Overview

Phase
Early Phase 1
Intervention
vasopressin
Conditions
Injuries
Sponsor
The University of Texas Health Science Center at San Antonio
Enrollment
81
Locations
1
Primary Endpoint
The Primary Endpoint of This Study Will be Day 30 Mortality.
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.

Registry
clinicaltrials.gov
Start Date
February 2007
End Date
February 2011
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • To be eligible for enrollment in the study, a patient must meet all of the follow criteria at assessment:
  • Patient is a male or female patient presumed to be at least 18 years of age;
  • Patient has a systolic blood pressure \< 90 mmHg;
  • Patient has clinical evidence of acute traumatic injury;
  • Infusion of study drug must start within one hour following SBP (systolic blood pressure) \< 90 mmHg

Exclusion Criteria

  • A patient meeting any one of the following criteria at hospital assessment is not eligible for enrollment:
  • Patient is admitted to one of the study hospitals' Emergency Department greater than six hours after injury;
  • Patient has received greater than 4 liters fluid since time of injury;
  • Patient is enrolled in another shock trial;
  • Patient is asystolic or requires CPR (cardiopulmonary resucitation) prior to randomization;
  • Female patient is pregnant by report or suspicion;
  • Patient has known "Do Not Resuscitate" orders or visible/identifiable method of objection to participation (e.g., exclusion bracelet);

Arms & Interventions

I

Vasopressin

Intervention: vasopressin

2

bolus of NS (normal saline) followed by continuous infusion of NS, no vasopressin added

Intervention: normal saline control

Outcomes

Primary Outcomes

The Primary Endpoint of This Study Will be Day 30 Mortality.

Time Frame: 30 days

Survival of a traumatic injury subject to at least 30 days after admission to the emergency room.

Secondary Outcomes

  • Level of Vasopressin After Trauma.(12 hours)

Study Sites (1)

Loading locations...

Similar Trials